BRF (BRFS3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
27 Dec, 2025Executive summary
Achieved record operational and financial results in 2024, with net revenue up 14–14.5% year-over-year to BRL 61.4 billion and net income of BRL 3.7 billion, reversing a loss in 2023 and enabling the first dividend payment since 2016.
EBITDA reached BRL 10.5 billion, more than double the previous year and the highest in company history, with operational efficiency gains from the BRF+ program and strong brand execution.
Free cash flow hit a record BRL 6.5 billion, with a cash conversion rate above 60% and leverage reduced to 0.75–0.79x from 2x in 2023.
Strategic focus on operational efficiency, market expansion, and innovation drove performance, with strong results in both Brazil and international markets.
Major international moves included acquisitions in Saudi Arabia and China, and a 50% stake in Gelprime for gelatin and collagen production.
Financial highlights
Net revenue reached BRL 61.4 billion, up 14–14.5% year-over-year; gross profit was BRL 15.8 billion, with gross margin improving to 25.8%.
EBITDA was BRL 10.5 billion (17.1% margin), more than double the previous year; net profit totaled BRL 3.7 billion for 2024.
Free cash flow hit BRL 6.5 billion, with operating cash flow at nearly BRL 10.8 billion.
Net debt reduced to BRL 5.9–8.3 billion, with average debt maturity at 8.4 years.
Leverage (Net Debt/EBITDA) dropped to 0.75–0.79x from 2x in 2023.
Outlook and guidance
Entered 2025 in a strong position, with robust volume and market diversity, despite anticipated cost pressures and inflation.
Priorities for 2025 include embedding BRF+ in company culture, further operational and commercial improvements, market diversification, and sustainable growth.
Expectation of continued balanced supply and demand for poultry and pigs, supporting favorable protein prices.
Strategic investments planned for both Brazilian and international production platforms to maximize revenue and brand leadership.
Ongoing focus on value-added products and market diversification to sustain resilience and growth.
Latest events from BRF
- Record 2Q24: net income R$1.1B, EBITDA R$2.6B, leverage at nine-year low.BRFS3
Q2 20241 Feb 2026 - Record 3Q24: revenue up 12.4%, net income BRL 1.1B, leverage at historic low.BRFS3
Q3 202414 Jan 2026 - Record profit, revenue growth, and a merger with a 0.8521 share exchange ratio announced.BRFS3
Q1 202526 Dec 2025 - Merger with Marfrig and record EBITDA highlight robust growth despite export challenges.BRFS3
Q2 202523 Nov 2025 - Record sales and revenue growth, but lower profit and margins amid higher costs and export bans.BRFS3
Q3 202517 Nov 2025